Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE-063): A randomized, open-label, phase 3 trial in Asian patients
Background KEYNOTE-063 (NCT03019588) investigated pembrolizumab versus paclitaxel as second-line therapy in Asian patients with advanced programmed death ligand 1 (PD-L1)-positive (combined positive score >= 1) gastric/gastroesophageal junction (GEJ) cancer. Methods This randomized, open-label, p...
Saved in:
Main Authors: | Chung, Hyun Cheol, Kang, Yoon-Koo, Chen, Zhendong, Bai, Yuxian, Ishak, Wan Zamaniah Wan, Shim, Byoung Yong, Park, Young Lee, Koo, Dong-Hoe, Lu, Jianwei, Xu, Jianming, Chon, Hong Jae, Bai, Li-Yuan, Zeng, Shan, Yuan, Ying, Chen, Yen-Yang, Gu, Kangsheng, Zhong, Wen Yan, Kuang, Shu, Shih, Chie-Schin, Qin, Shu-Kui |
---|---|
Format: | Article |
Published: |
Wiley
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/33657/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A promising response of refractory uterine leiomyosarcoma to pembrolizumab and temozolomide combination therapy
by: Lin, Rebecca, et al.
Published: (2024) -
Cost-effective analysis of proton pump inhibitors in long-term management of Gastroesophageal reflux disease: a narrative review
by: Jamshed, Shazia Qasim, et al.
Published: (2020) -
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
by: Rischin, Danny, et al.
Published: (2022) -
Merendino procedure as an alternative to total gastrectomy in the treatment of gastrointestinal stromal tumors of the gastroesophageal junction: A case series
by: Nakhieeran Nallasamy, et al.
Published: (2022) -
Dual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
by: Von Cheong, E., et al.
Published: (2021)